CN Patent

CN118556063A — 杂环类化合物、药物组合物及其应用

Assigned to Shanghai Pailong Biotechnology Co ltd · Expires 2024-08-27 · 2y expired

What this patent protects

本发明提供了一种杂环类化合物、药物组合物及其应用。并具体公开了如式(I‑0)所示的杂环类化合物、其药学上可接受的盐、其立体异构体或它们的溶剂合物。本发明化合物结构新颖，活性和选择性较好。

USPTO Abstract

本发明提供了一种杂环类化合物、药物组合物及其应用。并具体公开了如式(I‑0)所示的杂环类化合物、其药学上可接受的盐、其立体异构体或它们的溶剂合物。本发明化合物结构新颖，活性和选择性较好。

Drugs covered by this patent

Patent Metadata

Patent number
CN118556063A
Jurisdiction
CN
Classification
—
Expires
2024-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Pailong Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.